Events & Presentations

Document	Type
Feb 26, 2021	Corporate Presentation 6.3 MB

Date	Event Details	Remind Me
Apr 29, 2021 4:30 PM EDT	MacroGenics, Inc. First Quarter 2021 Financial Results Conference Call Listen to webcast	Add to Outlook Add to Google Calendar

Date	Event Details
Apr 10 - Apr 15, 2021	American Association for Cancer Research (AACR) Annual Meeting poster presentations: Supporting Materials Enhanced HER2-dependent immune activation by margetuximab supports combination with checkpoint blockade 991.2 KB Targeting B7-H3 in SCCHN: Preclinical proof-of-concept with MGC018, investigational anti-B7-H3 ADC 4.8 MB IMGC936 (investigational ADAM9-targeting ADC) is active against patient-derived ADAM9-expressing xenograft models 555.9 KB
Mar 11, 2021 3:45 PM EST	Barclays Global Healthcare Conference Listen to webcast
Mar 9, 2021	H.C. Wainwright & Co. Global Life Sciences Conference Listen to webcast
Feb 25, 2021 4:30 PM EST	MacroGenics, Inc. Fourth Quarter 2020 Financial Results Conference Call Listen to webcast
Dec 17, 2020 8:00 AM EST	MARGENZA™ Approval Conference Call Listen to webcast Supporting Materials View Presentation 1 MB
Dec 5 - Dec 8, 2020	62nd ASH Annual Meeting & Exposition Supporting Materials Microenvironmental Immune Senescence and Exhaustion in AML Associate w Response to Flotetuzumab 2.9 MB TP53 Abnormalities - Response to Flotetuzumab in AML (Rutella) 1 MB Flotetuzumab (CD123 x CD3) as Salvage Therapy for PIF and ER AML (Aldoss) 976.1 KB Flotetuzumab Upregulates MHC Class II Expression on AML (Rimando) 696.9 KB Immune Senescence and Exhaustion-Related RNA Profile Predicts Clinical Outcomes in AML (Rutella) 22.4 MB Phase 1 Study of MGD013 (Tebotelimab, PD-1 x LAG-3) in Patients with RR DLBCL (Wang) 912.2 KB Prophylactic Ruxolitinib for CRS in RR AML Pts Treated w Flotetuzumab (Uy) 653 KB
Nov 9 - Nov 13, 2020	The Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting Supporting Materials Ph. 1 Evaluation of Tebotelimab (PD-1 x LAG-3 DART® Molecule) in Combination with Margetuximab in Patients w/ Advanced HER2+ Neoplasms 1.7 MB
Nov 4, 2020 4:30 PM EST	MacroGenics, Inc. Third Quarter 2020 Financial Results Conference Call Listen to webcast
Sep 19 - Sep 21, 2020	ESMO Virtual Congress 2020 Supporting Materials ESMO 2020 - Retifanlimab (MGA012) POD1UM-201 Poster (Merkel Cell Carcinoma) 405.7 KB ESMO 2020 - Retifanlimab (MGA012) POD1UM-202 Presentation (Squamous Carcinoma of Anal Canal) 367.6 KB ESMO 2020 – MGD019 (PD-1 x CTLA-4) Phase 1 Dose Escalation Oral Presentation 1.4 MB
Jul 30, 2020 4:30 PM EDT	MacroGenics, Inc. Second Quarter 2020 Financial Results Conference Call Listen to webcast
Jun 22 - Jun 24, 2020	American Association for Cancer Research (AACR) Virtual Annual Meeting I Supporting Materials MGC018 1.2 MB CD25xCTLA-4 2 MB
May 29 - May 31, 2020	ASCO20 Virtual Scientific Program Supporting Materials ASCO 2020 - MGD013 Phase 1 2.3 MB ASCO 2020 - MGC018 Phase 1 1.8 MB ASCO 2020 - SOPHIA by Chemotherapy 187 KB
May 29, 2020 4:30 PM EDT	MacroGenics ASCO 2020 Conference Call Listen to webcast Supporting Materials View Presentation 4.1 MB
May 5, 2020 4:30 PM EDT	MacroGenics, Inc. First Quarter 2020 Financial Results Conference Call Listen to webcast
Apr 27 - Apr 28, 2020	American Society for Cancer Research (AACR) Virtual Annual Meeting I Supporting Materials View Presentation 7.3 MB
Feb 25, 2020 4:30 PM EST	MacroGenics, Inc. Fourth Quarter 2019 Financial Results Conference Call Listen to webcast
Dec 10 - Dec 14, 2019	2019 San Antonio Breast Cancer Symposium (SABCS) Supporting Materials View Presentation 1.4 MB SABCS – SOPHIA Infusion Substudy 470.9 KB
Dec 9, 2019 8:00 PM EST	MacroGenics Flotetuzumab Conference Call at ASH Listen to webcast Supporting Materials View Presentation 3.6 MB
Dec 7 - Dec 10, 2019	61st ASH Annual Meeting & Exposition Supporting Materials ASH2019-Godwin-flotetuzumab 5.9 MB ASH2019-Rutella-Flotetuzumab 7.8 MB ASH 2019 Flotetuzumab TIP 4.1 MB ASH 2019-Flotetuzumab-Clinical-Update 1 MB
Nov 6, 2019 4:30 PM EST	MacroGenics, Inc. Third Quarter 2019 Financial Results Conference Call Listen to webcast
Nov 6 - Nov 10, 2019	The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting Supporting Materials SITC - Tumor-targeted T-cell Activation via an Investigational PD-L1 x CD137 Bispecific Molecule 2.3 MB TiP-margetuximab 708.2 KB TiP-enoblituzumab 835 KB MGA012 (anti-PD-1 mAb) anal cancer (Incyte) 337.7 KB MGA012 (anti-PD-1 mAb) cervical cancer (Incyte) 367.6 KB
Sep 27 - Oct 1, 2019	2019 European Society for Medical Oncology (ESMO) Congress Supporting Materials ESMO 2019 – Margetuximab+Pembro GEA – Clinical 1.3 MB ESMO 2019 – Margetuximab+Pembro GEA - Survival 1.3 MB ESMO 2019 – Margetuximab+Pembro GEA - Biomarker 1.2 MB
Sep 25 - Sep 28, 2019	International Cancer lmmunotherapy Conference (CICON 2019) Supporting Materials Poster Presentation 2.2 MB
Jul 31, 2019 4:30 PM EDT	MacroGenics, Inc. Second Quarter 2019 Financial Results Conference Call Listen to webcast